Physarum polycephalum has no neurons, yet it builds efficient networks and solves mazes using pure bioelectric oscillation. Here's how, and why it matters for computing.
⚡ News
. brain-computer interface,brain-computer interface home use,FDA clearance,implanted neurostimulator regulation,neural implant,NeuroPace RNS wand,Stentrode,Synchron,Synchron Stentrode,wireless neural implant FDA clearance
The FDA has cleared Synchron's Stentrode for unsupervised home use, the first neural implant patients can run without a clinic wand or technician in the room.
Bioelectronics startup BackBeat Medical closed a $95M Series C to scale its implantable cardiac pacemaker-based system that reduces blood pressure without drugs — through precisely timed electrical pulses.
A new FDA-cleared device reads the spinal cord's electrical response in real time and adjusts its own stimulation parameters automatically — ending the era of manual pain device tuning.
Synchron has closed a $95M Series D to advance its minimally invasive brain-computer interface — a stent-like device implanted through a blood vessel that requires no open-brain surgery.
The FDA has granted Breakthrough Device Designation to a closed-loop spinal cord stimulator that automatically adjusts stimulation in real time based on neural feedback.
Medtronic's BrainSense Adaptive DBS system — cleared by the FDA in 2025 — is the first brain implant that reads neural signals in real time and adjusts its own stimulation accordingly. The era of closed-loop brain medicine has begun.
A wearable bioelectric patch delivering calibrated electrical fields to damaged tissue achieved healing rates three times faster than standard care in a Phase II trial.